Since Ansell, Crook, Mallard, and Bywaters (1963) and Makin and Robin (1964) initiated the method, the use of radioactive colloids in the treatment of chronic synovitis has become routine. The destruction of the inflammatory synovium, called synoviorthese or synoviolysis, is based on the irradiation of the serosa by colloidal particles, removed from the suspension injected into the articular cavity (Ballabio, Schiavetti, Caruso, and Merola, 1972; Bonneton, 1972; Webb, Lowe, and Bluestone, 1969) .
After injection, the radioactive colloid becomes distributed in the joint in the shape of the synovium, so that a scintigram shows a very similar distribution to that seen in an arthrogram (Fig. 1) . The aim of the radiotherapist is to ensure that the energy of the ionizing radiation is absorbed in the synovium only. We must therefore consider the characteristics of the radio pharmaceuticals used for intra-articular therapy, and also the possibility of transfer of energy to tissues which must be preserved from irradiation (Ingrand, 1972; Roucayrol, 1972; Stevenson, Bedford, Hill, and Hill, 1971 b) .
The radiation emitted by the colloidal particles may irradiate not only the synovium but also the cartilage and bone marrow (Bonneton, 1972) , depending on the range of emission of the radioisotope. Fortunately, autoradiographs show that the cartilaginous surface is usually free of radioactivity, which is concentrated in the synovium (Fig. 2) . Consequently, the use of a colloid tends to result in localized irradiation, but there remains the possibility of leakage away from the joint via the lymphatic system. These problems have been the basis of a multi-disciplinary study at the Hopital Cochin (Delbarre, Cayla, Aignan, Roucayrol, Menkes, and Ingrand, 1968; Menkes, Aignan, Galmiche, and Le Go, 1972) . Physical characteristics of radio-isotopes The destruction of the inflammatory synovitis, the biological effect we seek (Aignan and Tesson-Millet, 1972; Ballabio and others, 1972; Guiraudon (1972) , depends essentially on the energy absorbed on the surface and inside the serosa. This energy is dissipated along their course by the rays emitted by the radioactive colloidal particles.
There are two important factors: the total energy emitted during the decay of all the radionuclides; and the thickness of the tissue which it is required to irradiate. The total energy depends on the amount of activity injected, on the energy of I-emission, and on the half-life of the radio-isotope. The thickness of tissue irradiated is related to the energy of/I-emission and to the energy needed to create a pair of ions in the affected area. These data enable us to define a range, along which interactions can take place.
The principal characteristics of the radionuclides used for synoviotherapy are shown in Table I . It must be noted that the y-radiation of '98Au is actually a parasitic radiation in this treatment, as its energy is released not only in the joint but also far away from it. Because of this, we have abandoned the use of 198Au and replaced it with rhenium 186 (186Re), as the latter has a similar half-life and /I-energy, without the y-emission (Bardy, Beydon, and Hegesippe, 1973; Delbarre, Menkes, Aignan, Roycayrol, Ingrand, and Sanchez, 1973) .
Characteristics of radiopharmaceuticals Radiopharmaceuticals must satisfy certain criteria of purity and general specifications (Cohen, 1970 (Cohen, , 1972 . Usually these depend on the manufacturer, who must be responsible for the necessary controls and inform the user accordingly. Certain characteristics are important in determining the therapeutic effect or possible adverse side-effects.
(1) Size of colloidalparticles
The question of the most suitable size of the colloidal particles has been examined in reviews of their therapeutic application (Muller, 1962) . It is necessary to reach a compromise in determining the size needed for intra-articular therapy. A small diameter (10 nm.) allows the synovium to be homogeneously irradiated, but seems to be associated with a high frequency of extra-articular spread, whereas a large particle of several hundred nm. may give rise to a variable irradiation of the synovial membrane. To illustrate this, I have tried to relate particle size to the degree of spread found by various authors (Table  II) . While the various preparations of 198Au are homogeneous, there is considerable variation in the size of the particles of erbium 169 citrate (169Er), rhenium 186 sulphide ('86Re) (Fig. 3) , and yttrium 90 citrate (90Y).
The specialist in colloidal chemistry must work within narrow margins. He must present a product of which the pH, composition, and ionic strength are physiologically compatible, and at the same time he knows that these conditions will be unfavourable to the delicate process of controlling the growth in diameter of a colloidal particle. Ideally, he will achieve a homogeneous colloid with a particle size around 100 nm. Another problem is that the factors involved in the phenomenon of lymphatic spread are not yet clearly elucidated but, as others will consider this problem later, I will mention only the variability of the individual response and the importance of splinting and resting treated patients (Gumpel, Williams, and Glass, 1972; Ingrand, 1972; Rekonen, Oka, and Ruotsi, 1972; Oka, Isomaki, Rekonen, Ruotsi, and Seppala, 1972) .
One final point about the chemistry of radiocolloids. The majority are made up of an element from classical inorganic chemistry (precious metals and rare earths) but synthetic resins have also been suggested. Their homogeneous size is an advantage, as the radioactive material can be absorbed onto calibrated particles. As they cannot be destroyed in vivo, the resins may later induce a process of rejection; a process that is more probable with repeated injections.
(2) Radiochemical purity and specific activity Every metal transformed to a colloidal form loses the biochemical and physiological properties of its soluble form. For in chrysotherapy, and colloidal gold, yttrium, erbium, and rhenium should therefore be considered only as radioactive carriers useful at the microscopic level. Radiochemical purity is defined as the ratio of the radioactivity of the element in the desired chemical form to the total radioactivity of the same element in all the chemical forms present (Cohen, 1970) . Impurities may be present whose chemical or biological behaviour may differ from that of the desired colloidal form. In the radiocolloids used for synoviotherapy, we are concerned with the presence of soluble components which could induce toxic or allergic reactions (Table III) . In this field, it is not easy to define what is an adequate radiation dose. The absorbed dose, calculated in rads, depends not only on the radioisotope (energy of fl-emission and half-life) and the injected amount (activity in mCi.), but also on the final distribution of the radioactivity (shape and volume). This latter is a factor beyond our control. As the particles are taken up from the synovial fluid in the first hours after the injection, the shape of their distribution varies very greatly from patient to patient (Figs 4, 5, and 6), while the thickness of the pannus and the way the membrane is thrown into folds influence the volume of tissue irradiated. Both of these factors influence the evaluation of the therapeutic effect.
It is therefore easy to understand that on the whole the determination of the radiation dose given to the patient has been empirical. We now know that the therapeutic effect of 1 mCi. 198Au is not enough in the knee (Fellinger and Schmid, 1952) , whereas (overleaf) . In the first he has calculated the absorbed dose in terms of 90Y bound on the synovial membrane (plane source) and suspended in synovial fluid (volume source); the second shows the variation of the absorbed dose with the depth of the tissue.
Using the classical equation for f-dosimetry (Loevinger, Japha, and Brownell, 1956 ) and the 10,000 r dose known to be sufficient, we have calculated the tissue concentration of several isotopes. It is only relative, in that it assumes homogeneous distribution of radioactivity in the synovium without extra-articular leakage, but it may nevertheless be of use as a reference when replacing one radio-isotope with another of different physical characteristics (Table VI) . 
METHOD OF INJECTION
The injection is usually composed oflocal anaesthetic, the radiocolloid variably diluted with saline, and a corticosteroid. Except in the case of the knee, x-ray contrast medium is used to check the position of the needle in the joint and to show any communication with serous bursae or with the synovial sheath. When removing the needle, back-flow at the point of injection through the skin and underlying tissues of even a very small amount of concentrated radioactivity may be the direct cause of radionecrosis. To avoid this a three-way tap is used and the needle is flushed before removal with saline or other rinsing solution.
IMMOBILIZATION
The final and most essential precaution is to immobilize the treated joint for 48 hours. This simple operation greatly reduces the amount ofradioactivity which may escape.
Assessment
An objective assessment ofthe therapeutic result may be obtained by arthroscintigraphy with technetium 99 M pertechnetate (Delbarre, Menkes, Prin, Roucayrol, Ingrand, Rebut, and Aignan, 1971) . Conclusion In 1973, radioactive intra-articular therapy has clearly passed beyond its infancy as far as radio pharmaceuticals are concerned. The rheumatologist now has a rich stock of a-emitters, well adapted to the problems of the joints to be treated. The characteristics of the radiocolloids have been greatly improved, except perhaps for the size of the colloidal particles.
In the future, research in this field should be focused on the following interesting problems: finding new and better inert substrates for radioactivity and synthesizing those molecules which possess a selective tropism for the pathological cellular elements of the synovial membrane. Discussion DR. ROBERTS I should like to ask Professor Ingrand about the results in his patients following the injection of the cocktail that he describes. It may be the experience of others that intra-articular steroids produces benefit which is temporary and I wonder if the considerable reduction in dose that you were able to achieve may in fact have been at the expense of a reduction in the duration of the benefit brought about by the introduction of a small amount of corticosteroids into the joint. PROF. INGRAND The experiments on dose of radiocolloids were made using the same amount of corticosteroid, whether we used 3 or 6 mCi. DR. ANDREWS You showed some beautiful pictures of the distribution of radioactivity in knees. Have you any data on whether the distribution of activity within a given joint is in any way related to the route of injection? PROF. INGR AND I suppose the route of administration is not very important in the knee, because we can approach it from the outer or the inner aspect. Pouches and bursae do not always communicate with the general synovial cavity. In this case we are obliged to inject twice, first in the normal cavity and, if after scanning we see there is no activity in the nearby cavity, we must inject directly into the cavity. Nevertheless, radioactivity is homogeneously distributed in most cases, even when the patient is immobilized. There is a spontaneous diffusion of the radiocolloid in the synovial fluid in which histocytic reactions occur. Sometimes there appear to be regions without histocytic activity and in these cases one may anticipate a less satisfactory result of the treatment. But, as happens with many immunological reactions, we may often have good results even if the theoretical result does not seem to be good. MR. LAURENCE In relation to those scintigraphic pictures which were very beautiful, I wondered if you had any information whether the intensity of uptake by the synovium was related to the virulence of the inflammation. I ask this because perhaps those areas which were able to take up the isotope most easily and in highest doses might not be the areas responsible for the effusion, but were the areas more physiological in their function of absorption; therefore possibly you were getting a therapeutic dose in the areas where the synovium was less severely diseased. Have you any information on this topic ? PROF. INGRAND I have tried to compare in the same patients the scintigraphic pattem of radioactivity after intra-articular injection of a radiopharmaceutical and after intravenous injection of technetium 99 M pertechnetate (99mTc), or after intra-articular injection of 99mTc, which concentrates in areas of inflammatory activity. Sometimes there is a good correlation between the two, but in other cases there are marked differences in their distribution, but even in this theoretically unfavourable condition there can be a good therapeutic effect.
